Skip to content

Sedative and tranquilising acupuncture in the treatment of primary insomnia with anxiety

Clinical effects of sedative and tranquilising acupuncture in the treatment of primary insomnia with anxiety in different Traditional Chinese Medicine constitutions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10474528
Enrollment
120
Registered
2024-06-04
Start date
2020-08-20
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with primary insomnia with anxiety Mental and Behavioural Disorders

Interventions

A total of 113 patients who met the inclusion criteria were selected for this study using a convenience sampling method. The simple random sampling method was used to divide them into a treatment grou

Sponsors

Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Those who met the above diagnostic criteria of primary insomnia and anxiety state 2. Age between 18 and 65 years, with no restriction on gender 3. Those who have not taken other anti-insomnia and anxiety medication in the last month 4. Permission was obtained from the patient

Exclusion criteria

Exclusion criteria: 1. Those who did not meet the above inclusion criteria 2. Age 65 years, and pregnant or lactating women 3. Individuals with combined visceral diseases, severe diseases of the immune and blood systems, mental illnesses and recent neurological injuries such as traumatic brain injury or spinal cord injury 4. Skin infection at the acupoint area

Design outcomes

Primary

MeasureTime frame
Primary insomnia assessed using the Pittsburgh Sleep Quality Index (PSQI) after 4 and 8 weeks of treatment

Secondary

MeasureTime frame
1. Anxiety states assessed using the Self-Assessment Scale (SAS) after 4 and 8 weeks of treatment 2. Depressive states assessed using the Self-Rating Depression Scale (SDS) after 4 and 8 weeks of treatment

Countries

China

Contacts

Public ContactPeng Bai
baipeng_bp3147@163.com+86 (0)1084980281

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026